Jeremy Grantham's VRNA Position Overview
Jeremy Grantham (via Grantham, Mayo, Van Otterloo & Co. LLC) currently holds 264,115 shares of Verona Pharma plc (VRNA) worth $28.18 M, representing 0.08% of the portfolio. First purchased in 2025-Q3, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Jeremy Grantham has initiated a new position in VRNA, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Jeremy Grantham's Verona Pharma plc (VRNA) Holding Value Over Time
Track share changes against reported price movement
Quarterly Verona Pharma plc (VRNA) Trades by Jeremy Grantham
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2025 | +264,115 | New Buy | 264,115 | $106.71 |
Jeremy Grantham's Verona Pharma plc Investment FAQs
Jeremy Grantham first purchased Verona Pharma plc (VRNA) in Q3 2025, acquiring 264,115 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jeremy Grantham has held Verona Pharma plc (VRNA) for 1 quarters since Q3 2025.
Jeremy Grantham's largest addition to Verona Pharma plc (VRNA) was in Q3 2025, adding 264,115 shares worth $28.18 M.
According to the latest 13F filing for Q3 2025, Jeremy Grantham's firm, Grantham, Mayo, Van Otterloo & Co. LLC, owns 264,115 shares of Verona Pharma plc (VRNA), valued at approximately $28.18 M.
As of the Q3 2025 filing, Verona Pharma plc (VRNA) represents approximately 0.08% of Jeremy Grantham's publicly disclosed stock portfolio, making it one of their key holdings.
Jeremy Grantham's peak holding in Verona Pharma plc (VRNA) was 264,115 shares, as reported at the end of Q3 2025.